Skip to main navigation Skip to search Skip to main content

A Phase 3, Open-Label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-Pubertal Children with Growth Hormone Deficiency

University at Buffalo

Project: Research

Project Details

StatusActive
Effective start/end date09/20/17 → 12/31/26

Funding

  • Clinical Professionals Incorporated: $95,986.93